Have any questions? 706-721-6582 or cts@augusta.edu
Women age 18 years and older who have recently had an abnormal Pap smear and an abnormal cervical biopsy may be able to participate in a study of a new medication, VGX-3100. The study is double-blind and participants may receive the study medication or placebo (an inactive substance). Study participation will last approximately 88 weeks.